中文

OsteoScaf


Based on almost 10 years of research in materials and biological design, TRT’s wholly owned subsidiary BoneTec Corporation has developed OsteoScaf™: a fully resorbable, and osteoconductive material for bone augumentation with robust handling characteristics. OsteoScaf™ has been granted 510(K) clearance by the FDA and has shown excellent clinical results.


Some advantages of the proprietary TRT BoneTec OsteoScaf™ are:


  • Three phase fully resorbable system
  • Osteoconductive
  • Highly interconnected macroporosity mimicking natural bone architecture
  • Anti-Inflammatory
  • Mechanically robust: easy to handle at surgery and maintains original architecture even with cell seeding or host tissue invasion during healing










click here for our publications and patents